The US invests $3.2 billion to develop pills for COVID-19 and other viruses

The authorities announced a new antiviral program to combat pandemics.

The United States is investing $ 3.2 billion to develop pills for COVID-19 and other viruses that could trigger new pandemics.

As the leading US infectious diseases specialist Dr. Anthony Fauci told a White House briefing, the development of drugs will be part of a new initiative called the “Antiviral Program to Combat Pandemics.”

The program will support research to develop new drugs to address symptoms caused by the coronavirus and other potentially dangerous viruses.

COVID-19 tablets are already under development and could be available by the end of 2021 if clinical trials are successful. Earlier, the antiviral drug remdesivir was approved for the treatment of coronavirus in the United States.

If you have found a spelling error, please, notify us by selecting that text and pressing Ctrl+Enter.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Author: Steve Cowan
Graduated From Princeton University. He has been at the Free Press since October 2014. Previously worked as a regional entertainment editor.
Function: Chief-Editor
Steve Cowan

Spelling error report

The following text will be sent to our editors:

36 number 0.258946 time